These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 18292149)

  • 1. Long-term glucose variability and risk of nephropathy complication in UKPDS, ACCORD and VADT trials.
    Zhou JJ; Coleman R; Holman RR; Reaven P
    Diabetologia; 2020 Nov; 63(11):2482-2485. PubMed ID: 32954444
    [No Abstract]   [Full Text] [Related]  

  • 2. Retatruide' drug trial: A paradigm shift in Type 2 Diabetes management.
    Abbas Z; Saleem R
    J Pak Med Assoc; 2024 May; 74(5):1029-1030. PubMed ID: 38783470
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Vural Keskinler M; Telci Caklili O; Oguz A
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):894. PubMed ID: 37996194
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Ahmed A; Anker SD; Butler J; Bakris GL; Bhatt DL; Fonarow GC; Packer M
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):892-894. PubMed ID: 37996192
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial.
    Ceriello A; Prattichizzo F; Berra CC; Caballero AE
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):894-895. PubMed ID: 37996193
    [No Abstract]   [Full Text] [Related]  

  • 6. COMPARING PER-PROTOCOL EFFECT ESTIMATES FOR RANDOMIZED CLINICAL TRIALS IN POPULATION HEALTH: A REANALYSIS OF THE FEEDING AMERICA INTERVENTION TRIAL FOR HEALTH FOR DIABETES MELLITUS.
    Li CX; Cole SR; Seligman HK; Berkowitz SA
    Am J Epidemiol; 2023 Nov; 192(12):2094-2098. PubMed ID: 37420096
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing the effectiveness of glucose-lowering agents: real-world data to emulate a four-arm target trial - Authors' reply.
    Xie Y; Al-Aly Z
    Lancet Diabetes Endocrinol; 2023 Dec; 11(12):895-896. PubMed ID: 37996195
    [No Abstract]   [Full Text] [Related]  

  • 8. Shifting the disease management paradigm from glucose: what are the pros?
    Stirban A; Tschoepe D; Stratmann B
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S349-52. PubMed ID: 19875579
    [No Abstract]   [Full Text] [Related]  

  • 9. Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD.
    Hoogwerf BJ; ;
    Cleve Clin J Med; 2008 Oct; 75(10):729-37. PubMed ID: 18939389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive glucose control and cardiovascular outcomes in type 2 diabetes.
    Macisaac RJ; Jerums G
    Heart Lung Circ; 2011 Oct; 20(10):647-54. PubMed ID: 20807681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive glucose lowering arm of diabetes trial is stopped after excess deaths.
    Mayor S
    BMJ; 2008 Feb; 336(7641):407. PubMed ID: 18292149
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comment from the diabetology viewpoint].
    Stahl M
    Praxis (Bern 1994); 2008 Aug; 97(17):943-4. PubMed ID: 18777777
    [No Abstract]   [Full Text] [Related]  

  • 13. [Questions for practicing internists].
    Zinnenlauf S
    Praxis (Bern 1994); 2008 Aug; 97(17):945-6. PubMed ID: 18777778
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intensive therapy in type 2 diabetes. More damage than benefit?].
    Einecke D
    MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224
    [No Abstract]   [Full Text] [Related]  

  • 15. Importance of glycemic control.
    Shahady EJ
    J Fam Pract; 2011 Sep; 60(9 Suppl):S4-6. PubMed ID: 21912776
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.